About Kvantify
Kvantify is a company based in Copenhagen (Denmark) founded in 2022 by Allan Grønlund, Nikolaj Thomas Zinner, and Hans Henrik Knudsen. Kvantify has raised $18.86 million across 3 funding rounds from investors including European Union, Danmarks Eksport og Investeringsfond and Dreamcraft. The company has 67 employees as of November 30, 2024. Kvantify offers products and services including Kvantify Koffee, Computational Drug Discovery Platform, and Quantum Proof-of-Concepts. Kvantify operates in a competitive market with competitors including Aqemia, Kipu Quantum, QC Ware, NTxBio and Applied BioMath, among others.
- Headquarter Copenhagen, Denmark
- Employees 67 as on 30 Nov, 2024
- Founders Allan Grønlund, Nikolaj Thomas Zinner, Hans Henrik Knudsen
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kvantify Aps
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18.86 M (USD)
in 3 rounds
-
Latest Funding Round
$8.12 M (USD), Seed
Mar 06, 2026
-
Investors
European Union
& 7 more
-
Employee Count
67
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kvantify
Kvantify offers a comprehensive portfolio of products and services, including Kvantify Koffee, Computational Drug Discovery Platform, and Quantum Proof-of-Concepts.
Platform for binding affinity and kinetics calculations in small molecule research
Tools to improve compound screening using physics-based methods
Services to develop quantum applications for computing challenges
People of Kvantify
Unlock access to complete
Funding Insights of Kvantify
Kvantify has successfully raised a total of $18.86M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $8.12 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kvantify
Kvantify has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Danmarks Eksport og Investeringsfond and Dreamcraft.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech-driven companies are supported through early-stage venture investments.
|
Locked | Locked | Locked | |
|
Life science companies are funded through venture capital investments.
|
Locked | Locked | Locked | |
|
A private investment company focused on sustainability is operated.
|
Locked | Locked | Locked |
Investor details for Kvantify
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kvantify
Investment portfolio details for Kvantify
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kvantify
Detailed financials for Kvantify
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kvantify Comparisons
Peer comparison for Kvantify
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kvantify
Kvantify operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aqemia, Kipu Quantum, QC Ware, NTxBio and Applied BioMath, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic molecules are discovered through AI and quantum physics integration.
|
|
| Locked | Locked | Locked |
Quantum computing software solutions for optimization problems are provided.
|
|
| Locked | Locked | Locked |
A cloud-based quantum computing platform is provided by QC Ware.
|
|
| Locked | Locked | Locked |
Provider of bio informatics platform to develops biologics and therapeutics
|
|
| Locked | Locked | Locked |
Systems biology and pharmacology modeling services to aid drug discovery and development
|
|
| Locked | Locked | Locked |
Combinatorial chemistry services for peptide-based drug discovery are provided.
|
Detailed competitors of Kvantify
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kvantify
Complete news archive for Kvantify
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kvantify
Kvantify was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Kvantify is headquartered in Copenhagen, Denmark.
Hans Henrik Knudsen is the current CEO of Kvantify. They have also founded this company.
Kvantify is a funded company, having raised a total of $18.86M across 3 funding rounds to date.
As of Nov 30, 2024, the latest employee count at Kvantify is 67.
Kvantify is a company that provides off-the-shelf, sector-specific solutions for the financial services and life sciences industries. They use cutting-edge algorithms and quantum computing technology to address hard computational challenges. Kvantify aims to democratize access to advanced computing technology and help businesses contribute to a better future.
Kvantify's top competitors include Aqemia, NTxBio and Kipu Quantum.
Kvantify offers Kvantify Koffee, Computational Drug Discovery Platform, and Quantum Proof-of-Concepts.
Kvantify has 8 investors. Key investors include European Union, Danmarks Eksport og Investeringsfond, Dreamcraft, Lundbeck Foundation, and 2degrees.